Concepedia

Dinesh Thummuri

DT

30

Publications

2.7K

Citations

26

H-Index

2014

Active since

Affiliations

National Institute of Pharmaceutical Education and Research(Current)

University of Florida

National Institute of Pharmaceutical Education and Research

Indian Institute of Chemical Technology

The University of Texas Health Science Center at San Antonio

Dinesh Thummuri is an author at National Institute of Pharmaceutical Education and Research specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

2014–2023

30

Publications

30

A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity

Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 608 citations · Full text

, , +7

Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity

Yonghan He, Xuan Zhang, Jianhui Chang et al. · Nature Communications · 2020 · 246 citations · Full text

Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells

Shweta Shrivastava, Prasad V. Kulkarni, Dinesh Thummuri et al. · APOPTOSIS · 2014 · 147 citations

, , +9

Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,

Dongwen Lv, Pratik Pal, Xingui Liu et al. · Nature Communications · 2021 · 140 citations · Full text

Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling

Dinesh Thummuri, Manish Kumar Jeengar, Shweta Shrivastava et al. · Pharmacological Research · 2015 · 118 citations

, , +10

Rows per page

1–5 of 30